postgradmedj-2014-132696 Objectives Cardinal extrapyramidal features of progressive supranuclear palsy (PSP) help in clinically differentiating this condition from Parkinson’s disease and other Parkinsonian syndromes. However, not all extrapyramidal features may be initially present, thus posing a difficulty in early diagnosis. We studied their frequency at the time of first presentation. Methods Patients diagnosed clinically with PSP using the National Institute for Neurological Disorders and Society for PSP (NINDS/SPSP) criteria and seen betwee
The International Parkinson Disease and Movement Disorder Society PSP study group (IPMDS-PSP) recent...
The clinical diagnosis of progressive supranuclear palsy (PSP) relies on the identification of chara...
Although similar cases were described without pathologic correlation, progressive supranuclear palsy...
Objectives Cardinal extrapyramidal features of progressive supranuclear palsy (PSP) help in clinical...
Atypical Parkinsonian syndromes are a subset of progressive neurodegenerative disorders that present...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
BACKGROUND: Progressive supranuclear palsy (PSP) is a neuropathologically defined disease presenting...
BACKGROUND: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
The phenotypic variability of progressive supranuclear palsy (PSP) may account for its frequent misd...
IMPORTANCE: Patients with atypical parkinsonian syndromes (APS), including progressive supranuclear ...
Progressive supranuclear palsy (PSP1) causes progressive parkinsonism with prominent early postural ...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical parkinson...
The International Parkinson Disease and Movement Disorder Society PSP study group (IPMDS-PSP) recent...
The clinical diagnosis of progressive supranuclear palsy (PSP) relies on the identification of chara...
Although similar cases were described without pathologic correlation, progressive supranuclear palsy...
Objectives Cardinal extrapyramidal features of progressive supranuclear palsy (PSP) help in clinical...
Atypical Parkinsonian syndromes are a subset of progressive neurodegenerative disorders that present...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
BACKGROUND: Progressive supranuclear palsy (PSP) is a neuropathologically defined disease presenting...
BACKGROUND: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
The phenotypic variability of progressive supranuclear palsy (PSP) may account for its frequent misd...
IMPORTANCE: Patients with atypical parkinsonian syndromes (APS), including progressive supranuclear ...
Progressive supranuclear palsy (PSP1) causes progressive parkinsonism with prominent early postural ...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical parkinson...
The International Parkinson Disease and Movement Disorder Society PSP study group (IPMDS-PSP) recent...
The clinical diagnosis of progressive supranuclear palsy (PSP) relies on the identification of chara...
Although similar cases were described without pathologic correlation, progressive supranuclear palsy...